Products are for research use only, not for human use

Compound research hub

CJC-1295 without DAC: Research, Handling and Batch Documentation

CJC-1295 without DAC is modified GRF(1-29): a GHRH analogue with four substitutions that resist enzymatic cleavage, and no albumin-binding complex, so its half-life stays in the region of half an hour.

Part of Volta's peptides.

Identity and specification

Form
Lyophilized powder
Appearance
White lyophilised powder
Sequence, three-letter
Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg
CAS number
863288-34-0
Molecular formula
C₁₅₂H₂₅₂N₄₄O₄₂
Molecular weight
3,367.9 g/mol
Solubility
Soluble in sterile water
Shelf life
24 months from date of manufacture

Molecular structure, sequence and the published laboratory studies on CJC-1295 without DAC are in the compound library entry for CJC-1295 without DAC.

Vial sizes available

Every size of CJC-1295 without DAC Volta lists, in stock or not. Each is a separate catalogue page with its own batch number and specification table.

Purity and batch documentation

Volta's release specification is >99% (HPLC). That is a threshold we set. >99% is the specification every batch is released to. The figure on a certificate is what a laboratory measured for one lot.

No third-party certificate has been published for CJC-1295 without DACyet. The certificates Volta does publish, with the laboratory's own verification link on each, are in the certificate archive.

Handling and stability

Regulatory context

More peptides

CJC-1295 without DAC sits in Volta's peptides group, alongside the other compounds of the same composition. The whole range is on the full research catalogue, and the library of comparisons and guides is under peptide research.

Research use only. For in-vitro laboratory research by qualified professionals only. Not for human or animal administration. Not a drug, food, cosmetic or dietary supplement. Not intended to diagnose, treat, cure, mitigate or prevent any disease. Volta does not provide dosing, administration or protocol guidance for any material listed. Read the full research disclaimer.

Cluster last reviewed: 2026-09-15.

Your Cart

Your cart is empty

Browse our catalog to add research compounds.